rss
Ann Rheum Dis 2006;65:707-712 doi:10.1136/ard.2005.045872
  • Review

Swedish registers to examine drug safety and clinical issues in RA

  1. J Askling1,2,
  2. C M Fored1,
  3. P Geborek3,
  4. L T H Jacobsson4,
  5. R van Vollenhoven2,
  6. N Feltelius2,
  7. S Lindblad2,
  8. L Klareskog2
  1. 1Clinical Epidemiology Unit, Department of Medicine at Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden
  2. 2Department of Rheumatology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden
  3. 3Department of Rheumatology, Lund University Hospital, Lund, Sweden
  4. 4Department of Rheumatology, Malmö University Hospital and Lund University, Malmö, Sweden
  1. Correspondence to:
    Dr J Askling
    Clinical Epidemiology Unit M9:01, Department of Medicine, Karolinska University Hospital Solna, SE 171 76 Stockholm, Sweden; johan.askling{at}ki.se
  • Accepted 4 January 2006
  • Published Online First 13 January 2006

Abstract

Data from several different monitoring systems are examined. The potential for registers based on data obtained from clinical practice, and linkage of such data to national health and population registers, is discussed. The approach described is a possible prototype for long term surveillance systems needed for the safe introduction of new treatments.

Footnotes

  • Published Online First 13 January 2006

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. ard.2005.045872v1
    2. 65/6/707 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.